Table 1.
Effective Gene Dosage |
Other Phenotypes |
||||||||
Karyotype and Genotype | SRY | SOX9 | WT1 | SF1 | DMRT | DAX1 | PhenotypicSex | Human | Mouse |
46,XX: | |||||||||
Wild type | 0 | 2 | 2 | 2 | 2 | 2 | Female | ||
46,XY: | |||||||||
Wild type | 1 | 2 | 2 | 2 | 2 | 1 | Male | ||
SRY− | 0 | 2 | 2 | 2 | 2 | 1 | Female | Testicular dysgenesis | Not determined |
SOX9−/+ | 1 | 1 | 2 | 2 | 2 | 1 | Female | Campomelic dysplasia in XX and XY heterozygote | Not determined |
WT1−/+ | 1 | 2 | 1 | 2 | 2 | 1 | Female | Renal nephropathy, Wilms tumor in XX and XY heterozygote | Gonadal and kidney agenesis with defects in heart, lung in homozygote |
SF1−/+ | 1 | 2 | 2 | 1 | 2 | 1 | Female | AdrenalInsufficiency in heterozygote | Gonadal, adrenal, gonadotropic, and ventromedial-hypothalamus agenesis in homozygote |
DMRT−/+a | 1 | 2 | 2 | 2 | 1a | 1 | Female | Not determined | Not determined |
Duplication of Xp21(DAX1) | 1 | 2 | 2 | 2 | 2 | 2 | Female | Not applicable | Not applicable |
DAX1− | 1 | 2 | 2 | 2 | 2 | 0 | Male | Adrenal insufficiency, normal testes, sporadic hypogonadism/hypogonadotropism | Adrenal insufficiency, impaired spermatogenesis |
46,XX: | |||||||||
DAX1−/− | 1 | 2 | 2 | 2 | 2 | 0 | Female | Adrenal insufficiency, normal ovaries | Adrenal insufficiency, normal ovaries |
Large deletion spanning both DMRT1 and DMRT2 (Raymond et al. 1999).